Sian Bolitho

Our previous blogs ‘Ready to Exit – conduct a feasibility review first! and ‘Ready to Exit- Engage with potential buyers‘ discussed the need to ensure your company was ‘fit for sale’ and how to select who might be the most appropriate target buyers.  Having targeted and engaged with your potential buyers, what happens when one … Read more

Our previous blog “Ready to Exit – conduct a feasibility review first!” discussed the need to ensure your company was ‘fit for sale’ and that it was the right choice for owners and organisation alike. Having made the decision to move forward with the sale of your organisation, the next step on the journey is … Read more

When it comes to mergers and acquisitions (M&A) within the life sciences industry, we believe in simplifying the process into manageable modules. Companies can choose to tackle these sections sequentially or concentrate on one area at a time. Our recommended modular approach—Feasibility, Engagement, and Completion—offers a gradual, step-by-step process enabling businesses to make any necessary … Read more